Double-Action Lupus Drug Looks Good in Phase III Trial

(MedPage Today) — A new drug for systemic lupus erythematosus (SLE), first developed in China and approved there since 2021, worked well enough in a new placebo-controlled Phase III trial that its approval in Western countries appears possible. Called…